These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35296961)

  • 41. Cognitive impairment patterns in Parkinson's disease with visual hallucinations.
    Ozer F; Meral H; Hanoglu L; Ozturk O; Aydemir T; Cetin S; Atmaca B; Tiras R
    J Clin Neurosci; 2007 Aug; 14(8):742-6. PubMed ID: 17544275
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cognitive changes in Parkinson's disease patients with visual hallucinations.
    Ramirez-Ruiz B; Junque C; Marti MJ; Valldeoriola F; Tolosa E
    Dement Geriatr Cogn Disord; 2007; 23(5):281-8. PubMed ID: 17351320
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hallucinations in Parkinson's disease: a follow-up study.
    de Maindreville AD; Fénelon G; Mahieux F
    Mov Disord; 2005 Feb; 20(2):212-7. PubMed ID: 15390044
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quetiapine improves visual hallucinations in Parkinson disease but not through normalization of sleep architecture: results from a double-blind clinical-polysomnography study.
    Fernandez HH; Okun MS; Rodriguez RL; Malaty IA; Romrell J; Sun A; Wu SS; Pillarisetty S; Nyathappa A; Eisenschenk S
    Int J Neurosci; 2009; 119(12):2196-205. PubMed ID: 19916848
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Retrospective Neuropsychological Profile of Patients With Parkinson Disease Prior to Developing Visual Hallucinations.
    Muller AJ; O'Callaghan C; Walton CC; Shine JM; Lewis SJ
    J Geriatr Psychiatry Neurol; 2017 Mar; 30(2):90-95. PubMed ID: 28067106
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hallucinations in Parkinson disease.
    Diederich NJ; Fénelon G; Stebbins G; Goetz CG
    Nat Rev Neurol; 2009 Jun; 5(6):331-42. PubMed ID: 19498436
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Visual symptoms in Parkinson's disease and Parkinson's disease dementia.
    Archibald NK; Clarke MP; Mosimann UP; Burn DJ
    Mov Disord; 2011 Nov; 26(13):2387-95. PubMed ID: 21953737
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Deconstructing psychosis and misperception symptoms in Parkinson's disease.
    Nishio Y; Yokoi K; Uchiyama M; Mamiya Y; Watanabe H; Gang M; Baba T; Takeda A; Hirayama K; Mori E
    J Neurol Neurosurg Psychiatry; 2017 Sep; 88(9):722-729. PubMed ID: 28600444
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Psychometric Properties and Characteristics of the North-East Visual Hallucinations Interview in Parkinson's Disease.
    Holiday KA; Pirogovsky-Turk E; Malcarne VL; Filoteo JV; Litvan I; Lessig SL; Song D; Schiehser DM
    Mov Disord Clin Pract; 2017; 4(5):717-723. PubMed ID: 28435846
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A study of visual hallucinations in patients with Parkinson's disease.
    Klein C; Kömpf D; Pulkowski U; Moser A; Vieregge P
    J Neurol; 1997 Jun; 244(6):371-7. PubMed ID: 9249622
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Visual Hallucinations in Eye Disease and Lewy Body Disease.
    Urwyler P; Nef T; Müri R; Archibald N; Makin SM; Collerton D; Taylor JP; Burn D; McKeith I; Mosimann UP
    Am J Geriatr Psychiatry; 2016 May; 24(5):350-8. PubMed ID: 26796926
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk of Cognitive Impairment in Patients With Parkinson's Disease With Visual Hallucinations and Subjective Cognitive Complaints.
    Santos-García D; de Deus Fonticoba T; Cores Bartolomé C; Feal Painceiras MJ; Paz González JM; Martínez Miró C; Jesús S; Aguilar M; Pastor P; Planellas L; Cosgaya M; García Caldentey J; Caballol N; Legarda I; Hernández Vara J; Cabo I; López Manzanares L; González Aramburu I; Ávila Rivera MA; Gómez Mayordomo V; Nogueira V; Puente V; Dotor García-Soto J; Borrué C; Solano Vila B; Álvarez Sauco M; Vela L; Escalante S; Cubo E; Carrillo Padilla F; Martínez Castrillo JC; Sánchez Alonso P; Alonso Losada MG; López Ariztegui N; Gastón I; Kulisevsky J; Blázquez Estrada M; Seijo M; Rúiz Martínez J; Valero C; Kurtis M; de Fábregues O; González Ardura J; Alonso Redondo R; Ordás C; López Díaz L LM; McAfee D; Martinez-Martin P; Mir P;
    J Clin Neurol; 2023 Jul; 19(4):344-357. PubMed ID: 36647231
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Electroencephalographic-Based Functional Connectivity Networks of Visual Hallucinations and Visuospatial Dysfunctions in Parkinson's Disease.
    Kinugawa K; Mano T; Takatani T; Kido A; Sugie K
    Eur Neurol; 2022; 85(5):404-409. PubMed ID: 35483334
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regional cortical grey matter loss in Parkinson's disease without dementia is independent from visual hallucinations.
    Meppelink AM; de Jong BM; Teune LK; van Laar T
    Mov Disord; 2011 Jan; 26(1):142-7. PubMed ID: 20922809
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comprehensive identification of delusions and olfactory, tactile, gustatory, and minor hallucinations in Parkinson's disease psychosis.
    Kulick CV; Montgomery KM; Nirenberg MJ
    Parkinsonism Relat Disord; 2018 Sep; 54():40-45. PubMed ID: 29653909
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cortical and amygdalar Lewy body burden in Parkinson's disease patients with visual hallucinations.
    Papapetropoulos S; McCorquodale DS; Gonzalez J; Jean-Gilles L; Mash DC
    Parkinsonism Relat Disord; 2006 May; 12(4):253-6. PubMed ID: 16368258
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regional cerebral blood flow in Parkinson disease with nonpsychotic visual hallucinations.
    Oishi N; Udaka F; Kameyama M; Sawamoto N; Hashikawa K; Fukuyama H
    Neurology; 2005 Dec; 65(11):1708-15. PubMed ID: 16344511
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multimodal visual system analysis as a biomarker of visual hallucinations in Parkinson's disease.
    Diez-Cirarda M; Cabrera-Zubizarreta A; Murueta-Goyena A; Strafella AP; Del Pino R; Acera M; Lucas-Jiménez O; Ibarretxe-Bilbao N; Tijero B; Gómez-Esteban JC; Gabilondo I
    J Neurol; 2023 Jan; 270(1):519-529. PubMed ID: 36348068
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pareidolia in Parkinson's disease without dementia: A positron emission tomography study.
    Uchiyama M; Nishio Y; Yokoi K; Hosokai Y; Takeda A; Mori E
    Parkinsonism Relat Disord; 2015 Jun; 21(6):603-9. PubMed ID: 25864093
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dysfunction in attentional processing in patients with Parkinson's disease and visual hallucinations.
    Hall JM; O'Callaghan C; Shine JM; Muller AJ; Phillips JR; Walton CC; Lewis SJ; Moustafa AA
    J Neural Transm (Vienna); 2016 May; 123(5):503-7. PubMed ID: 26940598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.